Skip to search formSkip to main contentSkip to account menu

Aromatase Inhibitors

Known as: Androstenedione Aromatase Inhibitor, Estrogen Synthase Inhibitor, Estrogen Synthetase Inhibitor 
Any substance that inhibits aromatase, an enzyme responsible for the conversion of cholesterol to pregnenolone and the peripheral aromatization of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Over 40% of breast cancer patients are older than 70 years of age. In the last three decades, several clinical trials have… 
2007
2007
Combination therapy with clomiphene citrate plus gonadotropin (clomiphene citrate plus HMG) in induction ovulation reduce the… 
Review
2001
Review
2001
Abstract.Purpose: Endocrine therapy is a well-recognized approach to the treatment of postmenopausal patients with advanced… 
2000
2000
In patients with metastatic breast cancer, second-line therapy with aromatase inhibitors can improve survival in comparison with… 
1998
1998
Tamoxifen still is the mainstay of endocrine therapy in women with advanced breast cancer. Response rates in hormone receptor… 
1997
1997
Three-spined stickleback Gasterosteus aculeatus, males were implanted with Silastic capsules filled with different aromatase… 
Review
1988
Review
1988
The role of estrogen in promoting the growth of hormone-dependent mammary tumors is well established. Inhibition of estrogen… 
1984
1984
Derivatives of 19- azaandrostenedione (10 beta-amino-4- estrene -3,17-dione, 2) and 19-amino-4-androstene-3,17-dione (3) were… 
1983
1983
Aminoglutethimide (AG) has antitumor activity in disseminated breast cancer similar to that of surgical adrenalectomy. AG works…